Wolfgang Timmer
Robert Koch Allee 29
Gauting, BY 82131, Germany
Gauting, BY 82131, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Safety and pharmacokinetics of mosliciguat, a new, inhaled soluble guanylate cyclase activator, in healthy adult subjects.
Journal: British journal of clinical pharmacology
Published: June 16, 2025
Single dose escalation studies with inhaled POL6014, a potent novel selective reversible inhibitor of human neutrophil elastase, in healthy volunteers and subjects with cystic fibrosis.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: March 29, 2019
The safety, tolerability and pharmacokinetics of BI 409306, a novel and potent PDE9 inhibitor: Overview of three Phase I randomised trials in healthy volunteers.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: July 13, 2017
Allergen-induced asthmatic responses modified by a GATA3-specific DNAzyme.
Journal: The New England journal of medicine
Published: May 19, 2015
Once-daily tiotropium Respimat(®) 5 μg is an efficacious 24-h bronchodilator in adults with symptomatic asthma.
Journal: Respiratory medicine
Published: September 19, 2014
Safety and tolerability of a novel inhaled GATA3 mRNA targeting DNAzyme in patients with TH2-driven asthma.
Journal: The Journal of allergy and clinical immunology
Published: July 10, 2014
Evaluation of the effect of food and age on the pharmacokinetics of oral netupitant and palonosetron in healthy subjects: A randomized, open-label, crossover phase 1 study.
Journal: Clinical pharmacology in drug development
Published: June 30, 2014
Effects of combined netupitant and palonosetron (NEPA), a cancer supportive care antiemetic, on the ECG of healthy subjects: an ICH E14 thorough QT trial.
Journal: SpringerPlus
Published: April 10, 2014
First-in-human study of the safety, tolerability, pharmacokinetics and pharmacodynamics of abediterol (LAS100977), a novel long-acting Β2 -agonist.
Journal: Journal of clinical pharmacology
Published: April 04, 2014
Effect of netupitant, a highly selective NK₁ receptor antagonist, on the pharmacokinetics of palonosetron and impact of the fixed dose combination of netupitant and palonosetron when coadministered with ketoconazole, rifampicin, and oral contraceptives.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: September 27, 2012
Response to the letter by Dr Chin and co-workers.
Journal: British journal of clinical pharmacology
Published: July 06, 2012
Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin.
Journal: British journal of clinical pharmacology
Published: February 22, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026